GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Debt-to-Revenue

BDMD (Baird Medical Investment Holdings) Debt-to-Revenue : 0.59 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Baird Medical Investment Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $14.17 Mil. Baird Medical Investment Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $1.35 Mil. Baird Medical Investment Holdings's annualized Revenue for the quarter that ended in Jun. 2024 was $26.27 Mil. Baird Medical Investment Holdings's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 0.59.

Baird Medical Investment Holdings Debt-to-Revenue Historical Data

The historical data trend for Baird Medical Investment Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Debt-to-Revenue Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Revenue
0.11 0.21 0.37

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Debt-to-Revenue N/A N/A - 0.29 0.59

Competitive Comparison of Baird Medical Investment Holdings's Debt-to-Revenue

For the Medical Devices subindustry, Baird Medical Investment Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baird Medical Investment Holdings's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Debt-to-Revenue falls into.


Baird Medical Investment Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Baird Medical Investment Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(9.488 + 2.026) / 31.458
=0.37

Baird Medical Investment Holdings's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(14.166 + 1.351) / 26.274
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.

Baird Medical Investment Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Debt-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.